Targeting B-cell anergy in chronic lymphocytic leukemia.

Benedetta Apollonio, Cristina Scielzo, Maria Teresa Sabrina Bertilaccio, Elisa Ten Hacken, Lydia Scarfò, Pamela Ranghetti, Freda Stevenson, Graham Packham, Paolo Ghia, Marta Muzio, Federico Caligaris-Cappio

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

B-cell receptor (BCR) triggering and responsiveness have a crucial role in the survival and expansion of chronic lymphocytic leukemia (CLL) clones. Analysis of in vitro response of CLL cells to BCR triggering allowed the definition of 2 main subsets of patients and lack of signaling capacity was associated with constitutive activation of extracellular-regulated kinases 1/2 (ERK1/2) and nuclear factor of activated T cells c1 (NF-ATc1), consistent with the idea that at least one group of CLL patients derives from the abnormal expansion of anergic B cells. In the present work, we further investigated the anergic subset of CLL (defined as the one with constitutive ERK1/2 phosphorylation) and found that it is characterized by low levels of surface immunoglobulin M and impairment of calcium mobilization after BCR engagement in vitro. Chronic BCR triggering promoted CLL cell survival selectively in phosphorylated ERK1/2 samples and the use of mitogen-activated protein kinase and NF-AT signaling inhibitors specifically induced apoptosis in this group of patients. Apoptosis induction was preceded by an initial phase of anergy reversal consisting in the loss of ERK phosphorylation and NF-AT nuclear translocation and by the restoration of BCR responsiveness, reinforcing the idea that the anergic program favors the survival of leukemic lymphocytes.

Original languageEnglish
JournalBlood
Volume121
Issue number19
DOIs
Publication statusPublished - May 9 2013

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Phosphorylation
B-Lymphocytes
Phosphotransferases
Cells
Apoptosis
NFATC Transcription Factors
B-Cell Antigen Receptors
Lymphocytes
Mitogen-Activated Protein Kinases
Restoration
Immunoglobulin M
Chemical activation
Calcium
Cell Survival
Clone Cells
Survival

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Apollonio, B., Scielzo, C., Bertilaccio, M. T. S., Ten Hacken, E., Scarfò, L., Ranghetti, P., ... Caligaris-Cappio, F. (2013). Targeting B-cell anergy in chronic lymphocytic leukemia. Blood, 121(19). https://doi.org/10.1182/blood-2012-12-474718

Targeting B-cell anergy in chronic lymphocytic leukemia. / Apollonio, Benedetta; Scielzo, Cristina; Bertilaccio, Maria Teresa Sabrina; Ten Hacken, Elisa; Scarfò, Lydia; Ranghetti, Pamela; Stevenson, Freda; Packham, Graham; Ghia, Paolo; Muzio, Marta; Caligaris-Cappio, Federico.

In: Blood, Vol. 121, No. 19, 09.05.2013.

Research output: Contribution to journalArticle

Apollonio, B, Scielzo, C, Bertilaccio, MTS, Ten Hacken, E, Scarfò, L, Ranghetti, P, Stevenson, F, Packham, G, Ghia, P, Muzio, M & Caligaris-Cappio, F 2013, 'Targeting B-cell anergy in chronic lymphocytic leukemia.', Blood, vol. 121, no. 19. https://doi.org/10.1182/blood-2012-12-474718
Apollonio B, Scielzo C, Bertilaccio MTS, Ten Hacken E, Scarfò L, Ranghetti P et al. Targeting B-cell anergy in chronic lymphocytic leukemia. Blood. 2013 May 9;121(19). https://doi.org/10.1182/blood-2012-12-474718
Apollonio, Benedetta ; Scielzo, Cristina ; Bertilaccio, Maria Teresa Sabrina ; Ten Hacken, Elisa ; Scarfò, Lydia ; Ranghetti, Pamela ; Stevenson, Freda ; Packham, Graham ; Ghia, Paolo ; Muzio, Marta ; Caligaris-Cappio, Federico. / Targeting B-cell anergy in chronic lymphocytic leukemia. In: Blood. 2013 ; Vol. 121, No. 19.
@article{8298420b89a64aed8bde1e38a33d5617,
title = "Targeting B-cell anergy in chronic lymphocytic leukemia.",
abstract = "B-cell receptor (BCR) triggering and responsiveness have a crucial role in the survival and expansion of chronic lymphocytic leukemia (CLL) clones. Analysis of in vitro response of CLL cells to BCR triggering allowed the definition of 2 main subsets of patients and lack of signaling capacity was associated with constitutive activation of extracellular-regulated kinases 1/2 (ERK1/2) and nuclear factor of activated T cells c1 (NF-ATc1), consistent with the idea that at least one group of CLL patients derives from the abnormal expansion of anergic B cells. In the present work, we further investigated the anergic subset of CLL (defined as the one with constitutive ERK1/2 phosphorylation) and found that it is characterized by low levels of surface immunoglobulin M and impairment of calcium mobilization after BCR engagement in vitro. Chronic BCR triggering promoted CLL cell survival selectively in phosphorylated ERK1/2 samples and the use of mitogen-activated protein kinase and NF-AT signaling inhibitors specifically induced apoptosis in this group of patients. Apoptosis induction was preceded by an initial phase of anergy reversal consisting in the loss of ERK phosphorylation and NF-AT nuclear translocation and by the restoration of BCR responsiveness, reinforcing the idea that the anergic program favors the survival of leukemic lymphocytes.",
author = "Benedetta Apollonio and Cristina Scielzo and Bertilaccio, {Maria Teresa Sabrina} and {Ten Hacken}, Elisa and Lydia Scarf{\`o} and Pamela Ranghetti and Freda Stevenson and Graham Packham and Paolo Ghia and Marta Muzio and Federico Caligaris-Cappio",
year = "2013",
month = "5",
day = "9",
doi = "10.1182/blood-2012-12-474718",
language = "English",
volume = "121",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "19",

}

TY - JOUR

T1 - Targeting B-cell anergy in chronic lymphocytic leukemia.

AU - Apollonio, Benedetta

AU - Scielzo, Cristina

AU - Bertilaccio, Maria Teresa Sabrina

AU - Ten Hacken, Elisa

AU - Scarfò, Lydia

AU - Ranghetti, Pamela

AU - Stevenson, Freda

AU - Packham, Graham

AU - Ghia, Paolo

AU - Muzio, Marta

AU - Caligaris-Cappio, Federico

PY - 2013/5/9

Y1 - 2013/5/9

N2 - B-cell receptor (BCR) triggering and responsiveness have a crucial role in the survival and expansion of chronic lymphocytic leukemia (CLL) clones. Analysis of in vitro response of CLL cells to BCR triggering allowed the definition of 2 main subsets of patients and lack of signaling capacity was associated with constitutive activation of extracellular-regulated kinases 1/2 (ERK1/2) and nuclear factor of activated T cells c1 (NF-ATc1), consistent with the idea that at least one group of CLL patients derives from the abnormal expansion of anergic B cells. In the present work, we further investigated the anergic subset of CLL (defined as the one with constitutive ERK1/2 phosphorylation) and found that it is characterized by low levels of surface immunoglobulin M and impairment of calcium mobilization after BCR engagement in vitro. Chronic BCR triggering promoted CLL cell survival selectively in phosphorylated ERK1/2 samples and the use of mitogen-activated protein kinase and NF-AT signaling inhibitors specifically induced apoptosis in this group of patients. Apoptosis induction was preceded by an initial phase of anergy reversal consisting in the loss of ERK phosphorylation and NF-AT nuclear translocation and by the restoration of BCR responsiveness, reinforcing the idea that the anergic program favors the survival of leukemic lymphocytes.

AB - B-cell receptor (BCR) triggering and responsiveness have a crucial role in the survival and expansion of chronic lymphocytic leukemia (CLL) clones. Analysis of in vitro response of CLL cells to BCR triggering allowed the definition of 2 main subsets of patients and lack of signaling capacity was associated with constitutive activation of extracellular-regulated kinases 1/2 (ERK1/2) and nuclear factor of activated T cells c1 (NF-ATc1), consistent with the idea that at least one group of CLL patients derives from the abnormal expansion of anergic B cells. In the present work, we further investigated the anergic subset of CLL (defined as the one with constitutive ERK1/2 phosphorylation) and found that it is characterized by low levels of surface immunoglobulin M and impairment of calcium mobilization after BCR engagement in vitro. Chronic BCR triggering promoted CLL cell survival selectively in phosphorylated ERK1/2 samples and the use of mitogen-activated protein kinase and NF-AT signaling inhibitors specifically induced apoptosis in this group of patients. Apoptosis induction was preceded by an initial phase of anergy reversal consisting in the loss of ERK phosphorylation and NF-AT nuclear translocation and by the restoration of BCR responsiveness, reinforcing the idea that the anergic program favors the survival of leukemic lymphocytes.

UR - http://www.scopus.com/inward/record.url?scp=84880494754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880494754&partnerID=8YFLogxK

U2 - 10.1182/blood-2012-12-474718

DO - 10.1182/blood-2012-12-474718

M3 - Article

VL - 121

JO - Blood

JF - Blood

SN - 0006-4971

IS - 19

ER -